Apollo Hospitals announced robust Q2 FY26 results, showcasing a 13% YoY revenue increase to Rs. 6,304 Crore and a 15% YoY EBITDA growth to Rs. 941 Crore. The company’s diversified healthcare model, incorporating healthcare services, retail healthcare & diagnostics, and digital & pharma distribution, propelled this strong performance. Consolidated PAT grew 26% YoY to Rs. 477 Crore.
Financial Highlights
Apollo Hospitals reported significant growth in Q2 FY26:
- Revenues: Increased by 13% YoY to Rs. 6,304 Crore.
- EBITDA: Grew by 15% YoY to Rs. 941 Crore (includes Apollo 24/7 costs).
- PAT: Increased by 26% YoY to Rs. 477 Crore.
- Diluted EPS: Rs. 33.19 per share (not annualized).
Segment Performance
Healthcare Services
- Revenue: Rs. 3,169 Crore, up 9% YoY.
- EBITDA: Rs. 781 Crore, up 8% YoY with margins at 24.6%.
- PAT: Rs. 410 Crore, up 13% YoY.
Apollo Health and Lifestyle Limited
- Revenue: Rs. 474 Crore, up 17% YoY.
- EBITDA: Rs. 50 Crore, up 21% YoY with margins at 10.6%.
- PAT: Loss of Rs. 6 Crore.
Apollo HealthCo
- Revenue: Rs. 2,661 Crore, up 17% YoY.
- EBITDA: Rs. 110 Crore with margins at 4.1%.
- PAT: Rs. 73 Crore.
H1 FY26 Consolidated Results
The company also reported strong H1 FY26 consolidated results:
- Revenues: Up 14% YoY to Rs. 12,146 Crore.
- EBITDA: Up 20% YoY to Rs. 1,793 Crore.
- PAT: Up 33% YoY to Rs. 910 Crore.
Source: BSE
